ISSN: 1134-8046
e-ISSN: 2254-6189

Indexada en:

Busqueda avanzada

Año 2024 / Volumen 31 / Número 3

Abstract PDF HTML

Nota clínica

Síndrome de Parsonage-Turner: presentación atípica posterior a vacuna para COVID-19. Reporte de un caso y revisión de la literatura
Atypical Parsonage-Turner syndrome after COVID-19 vaccine. A case report and literature review

Rev. Soc. Esp. Dolor. 2024; 31(3): 169-175 / DOI: 10.20986/resed.2025.4120/2023

Rene A. Linares, José I. Linares, Hernando Rubiano, Jorge E. Gutiérrez

RESUMEN

El síndrome de Parsonage-Turner (SPT) se define como una neuropatía periférica axonal de comienzo agudo. Con mayor frecuencia se caracteriza por dolor severo, paresia progresiva unilateral en los miembros superiores y atrofia muscular. Es incapacitante en su fase aguda y puede producir discapacidad prolongada, que podría reducirse con un tratamiento oportuno. El SPT adquirió relevancia en el contexto de la pandemia por SARS-CoV-2 ya que ha sido asociado con múltiples desencadenantes que incluyen infección viral y vacunas, pero debido a su baja frecuencia suele no diagnosticarse. Aunque la electromiografía y la neurografía por resonancia magnética son útiles para confirmarlo, la clínica continúa siendo el método diagnóstico más fácil, confiable y costo-efectivo. Presentamos un paciente con SPT posterior a la vacuna contra COVID-19, cuyo diagnóstico inicial se basó en los hallazgos clínicos y la electromiografía. Se realizó además una revisión de la literatura relacionada.

ABSTRACT

Parsonage-Turner syndrome (PTS) is described as an acute onset axonal peripheral neuropathy. Severe pain, progressive unilateral upper limb paresis and muscle atrophy are common features. It is disabling in the acute phase and can lead to long-term disability, which can be reduced with prompt treatment. PTS became relevant in the context of the SARS-CoV-2 pandemic as it has been associated with multiple triggers, including viral infections and vaccines, but due to its low frequency it often goes undiagnosed. Clinical examination remains the simplest, most reliable and cost-effective diagnostic method, although electromyography and magnetic resonance neurography are useful for confirmation. We present a case of PTS following COVID-19 vaccination. The initial diagnosis was based on clinical findings and electromyography. A review of the relevant literature was also undertaken.

Artículo Completo

Nuevo comentario

Código de seguridad:

Comentarios

No hay comentarios para este artículo.

Bibliografía

1. Parsonage MJ, Turner JWA. Neuralgic amyotrophy: The shoulder-girdle syndrome. Lancet. 1948;251(6513):973-8. DOI: 10.1016/s0140-6736(48)90611-4.

DOI: 10.1016/S0140-6736(48)90611-4

2. Van Alfen N, van Engelen BGM. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain. 2006;129(Pt 2):438-50. DOI: 10.1093/brain/awh722.

DOI: 10.1093/brain/awh722

3. Beghi E, Kurland LT, Mulder DW, Nicolosi A. Brachial plexus neuropathy in the population of Rochester, Minnesota, 1970-1981. Ann Neurol. 1985;18(3):320-3. DOI: 10.1002/ana.410180308.

DOI: 10.1002/ana.410180308

4. Van Alfen N, van Eijk JJJ, Ennik T, Flynn SO, Nobacht IEG, Groothuis JT, et al. Incidence of neuralgic amyotrophy (parsonage turner syndrome) in a primary care setting - A prospective cohort study. PLoS One. 2015;10(5):e0128361. DOI: 10.1371/journal.pone.0 pool.

5. Gstoettner C, Mayer JA, Rassam S, Hruby LA, Salminger S, Sturma A, et al. Neuralgic amyotrophy: A paradigm shift in diagnosis and treatment. J Neurol Neurosurg Psychiatry. 2020;91(8):879-88. DOI: 10.1136/jnnp-2020-323164.

DOI: 10.1136/jnnp-2020-323164

6. Kuhlenbäumer G, Hannibal MC, Nelis E, Schirmacher A, Verpoorten N, Meuleman J, et al. Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat Genet. 2005;37(10):1044-6.

DOI: 10.1038/ng1649

7. Neubauer K, Boeckelmann D, Koehler U, Kracht J, Kirschner J, Pendziwiat M, et al. Hereditary neuralgic amyotrophy in childhood caused by duplication within the SEPT9 gene: A family study. Cytoskeleton (Hoboken). 2019;76(1):131-6. DOI: 10.1002/cm.21479.

DOI: 10.1002/cm.21479

8. Landsverk ML, Ruzzo EK, Mefford HC, Buysse K, Buchan JG, Eichler EE, et al. Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophy. Hum Mol Genet. 2009;18(7):1200-8. DOI: 10.1093/hmg/ddp014.

DOI: 10.1093/hmg/ddp014

9. Ismail II, Abdelnabi EA, Al-Hashel JY, Alroughani R, Ahmed SF. Neuralgic amyotrophy associated with COVID-19 infection: A case report and review of the literature. Neurol Sci. 2021;42(6):2161-5. DOI: 10.1007/s10072-021-05197-z.

DOI: 10.1007/s10072-021-05197-z

10. Finsterer J. Neurological adverse reactions to SARS-CoV-2 vaccines. Clin Psychopharmacol Neurosci. 2023;21(2):222-39. DOI: 10.9758/cpn.2023.21.2.222.

DOI: 10.9758/cpn.2023.21.2.222

11. Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci. 2022;43(1):3-40. DOI: 10.1007/s10072-021-05662-9.

DOI: 10.1007/s10072-021-05662-9

12. Ameer MZ, Haiy AU, Bajwa MH, Abeer H, Mustafa B, Ameer F, et al. Association of Parsonage-Turner syndrome with COVID-19 infection and vaccination: A systematic review. J Int Med Res. 2023;51(7):3000605231187939. DOI: 10.1177/03000605231187939.

DOI: 10.1177/03000605231187939

13. Van Eijk JJJ, Groothuis JT, van Alfen N. Neuralgic amyotrophy: An update on diagnosis, pathophysiology, and treatment. Muscle Nerve. 2016;53(3):337-50. DOI: 10.1002/mus.25008.

DOI: 10.1002/mus.25008

14. Feinberg JH, Radecki, J. Parsonage-turner syndrome. HSS J. 2010;6(2):199-205. DOI: 10.1007/s11420-010-9176-x.

DOI: 10.1007/s11420-010-9176-x

15. Van Alfen N, van Engelen BGM, Hughes RAC. Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis). Cochrane Database Syst Rev. 2009;2009(3):CD006976. DOI: 10.1002/14651858.CD006976.pub2.

DOI: 10.1002/14651858.CD006976.pub2

16. Naito KS, Fukushima K, Suzuki S, Kuwahara M, Morita H, Kusunoki S, et al. Intravenous immunoglobulin (IVIg) with methylprednisolone pulse therapy for motor impairment of neuralgic amyotrophy: Clinical observations in 10 cases. Intern Med (Tokyo, Japan). 2012;51(12):1493-500. DOI: 10.2169/internalmedicine.51.7049.

DOI: 10.2169/internalmedicine.51.7049

17. Mouliou DS, Dardiotis E. Current evidence in SARS-CoV-2 mRNA vaccines and post-vaccination adverse reports: Knowns and unknowns. Diagnostics (Basel). 2022;12(7):1555. DOI: https://doi.org/10.3390/diagnostics12071555.

DOI: 10.3390/diagnostics12071555

18. Mahajan S, Zhang F, Mahajan A, Zimnowodzki, S. ParsonageTurner syndrome after COVID-19 vaccination. Muscle Nerve. 2021;64(1):E3-4. DOI: 10.1002/mus.27255.

DOI: 10.1002/mus.27255

19. Crespo Burillo JA, Loriente Martínez C, García Arguedas C, Mora Pueyo FJ. Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine. Neurologia (Engl Ed). 2021;36(7):571-2. DOI: 10.1016/j.nrleng.2021.05.02.

20. Diaz-Segarra N, Edmond A, Gilbert C, Mckay O, Kloepping C, Yonclas P. Painless idiopathic neuralgic amyotrophy after COVID-19 vaccination: A case report. PM R. 2022;14(7):889-91. DOI: 10.1002/pmrj.12619.

DOI: 10.1002/pmrj.12619

21. Kim SI, Seok HY, Yi J, Cho JH. Leg paralysis after AstraZeneca COVID-19 vaccination diagnosed as neuralgic amyotrophy of the lumbosacral plexus: A case report. J Int Med Res. 2021;49(11): 3000605211056783. DOI: 10.1177/03000605211056783.

DOI: 10.1177/03000605211056783

22. Vitturi BK, Grandis M, Beltramini S, Orsi A, Schenone A, Icardi G, et al. Parsonage-Turner syndrome following coronavirus disease 2019 immunization with ChAdOx1-S vaccine: A case report and review of the literature. J Med Case Rep. 2021;15(1):589. DOI: https://doi.org/10.1186/s13256-021-03176-8.

DOI: 10.1186/s13256-021-03176-8

23. Coffman JR, Randolph AC, Somerson JS. Parsonage-Turner syndrome after SARS-CoV-2 BNT162b2 vaccine: A case report. JBJS Case Connect. 2021;11(3). DOI: 10.2106/JBJS.CC.21.00370.

DOI: 10.2106/JBJS.CC.21.00370

24. Civardi C, Delconte C, Pisano F, Collini A, Geda C. Isolated musculocutaneous involvement in neuralgic amyotrophy associated with SARS-CoV2 vaccination. Neurol Sci. 2022;43(6):3515-7. DOI: 10.1007/s10072-022-06004-z.

DOI: 10.1007/s10072-022-06004-z

25. Queler SC, Towbin AJ, Milani C, Whang J, Sneag DB. Parsonage-Turner syndrome following COVID-19 vaccination: MR Neurography. Radiology. 2022;302(1):84-7. DOI: 10.1148/radiol.2021211374.

DOI: 10.1148/radiol.2021211374

26. Min YG, Kim JE, Hwang JY, Shin JY, Sung JJ, Hong YH. Parsonage-Turner syndrome following COVID-19 vaccination. J Neurol Neurosurg Psychiatry. 2022;93(11):1231-2. DOI: 10.1136/jnnp-2021-328182.

DOI: 10.1136/jnnp-2021-328182

27. Chua MMJ, Hayes MT, Cosgrove R. Parsonage-Turner syndrome following COVID-19 vaccination and review of the literature. Surg Neurol Int. 2022;13:152. DOI: 10.25259/SNI_4_2022.

DOI: 10.25259/SNI_4_2022

28. Shields LBE, Iyer VG, Zhang YP, Burger JT, Shields CB. Parsonage-Turner syndrome following COVID-19 vaccination: Clinical and electromyographic findings in 6 patients. Case Rep Neurol. 2022;14(1), 58-67. DOI: 10.1159/000521462.

DOI: 10.1159/000521462

29. Amjad MA, Hamid Z, Patel Y, Husain M, Saddique A, Liaqat A, et al. COVID-19 vaccine-induced Parsonage-Turner syndrome: A case report and literature review. Cureus. 2022;14(5):e25493. DOI: 10.7759/cureus.25493.

DOI: 10.7759/cureus.25493

30. Öncel A, Coşkun E. Parsonage-Turner syndrome after SARS-CoV-2 vaccination: A case report. Turk J Phys Med Rehabil. 2022;68(3):418-21. DOI: 10.5606/tftrd.2022.10456.

DOI: 10.5606/tftrd.2022.10456

31. Sharma R, Dua B, Goyal S, Tiwari T. Parsonage-Turner syndrome following COVID-19 vaccine. Ann Indian Acad Neurol. 2022;25(5):973-5. DOI: 10.4103/aian.aian_354_22.

DOI: 10.4103/aian.aian_354_22

32. Lakkireddy M, Sathu S, Kumar R, Madhu Latha K, Maley DK. Parsonage-Turner syndrome following Covishield (AstraZeneca ChAdOx1 nCoV-19) vaccination: A case report. Cureus. 2022;14(8):e27867. DOI: 10.7759/cureus.27867.

DOI: 10.7759/cureus.27867

33. Mejri I, Ben Hmida L, Bedoui I, Znegui T, Kacem M, Moatemri Z, et al. Parsonage-Turner syndrome of the brachial plexus secondary to COVID-19 vaccine: A case report. Clin Case Rep. 2022;10(10):e6483. DOI: https://doi.org/10.1002/ccr3.6483.

DOI: 10.1002/ccr3.6483

34. Kang J, Cho JY. Diaphragmatic dysfunction due to neuralgic amyotrophy after SARS-CoV-2 vaccination: A case report. J Korean Med Sci. 2022;37(38):e283. DOI: 10.3346/jkms.2022.37.e283.

DOI: 10.3346/jkms.2022.37.e283

35. Bernheimer JH, Gasbarro G. Parsonage turner syndrome following vaccination with mRNA-1273 SARS-CoV-2 vaccine. J Clin Neuromuscul Dis. 2022;23(4):229-30. DOI: 10.1097/CND.0000000000000411.

DOI: 10.1097/CND.0000000000000411

36. Cassart EM, Vilas DR, Abe R, Cavanilles-Walker JM. Parsonage-Turner syndrome after COVID-19 vaccination in a child. J Am Acad Orthop Surg Glob Res Rev. 2023;7(3):e22.00156. DOI: 10.5435/JAAOSGlobal-D-22-00156.

DOI: 10.5435/JAAOSGlobal-D-22-00156

37. Meixedo S, Correia M, Machado Lima A, Carneiro I. Parsonage-Turner syndrome post-COVID-19 Oxford/AstraZeneca vaccine inoculation: A case report and brief literature review. Cureus. 2023;15(2):e34710. DOI: 10.7759/cureus.34710.

DOI: 10.7759/cureus.34710

38. Ishizuka K, Ohira Y. Winged scapula caused by Parsonage-Turner syndrome after bnt162b2 mRNA covid-19 vaccination. Eur J Case Rep Intern Med. 2023;10(2):003779. DOI: 10.12890/2023_003779.

DOI: 10.12890/2023_003779

39. Yeoh ZY, Ramdzan SN. Parsonage-Turner syndrome: A case report of a rare side effect of COVID-19 booster vaccination. Malays Fam Physician. 2023;18:21. DOI: 10.51866/cr.184.

DOI: 10.51866/cr.184

40. Sukockienė E, Breville G, Fayolle D, Nencha U, Uginet M, Hübers A. Case series of acute peripheral neuropathies in individuals who received COVID-19 vaccination. Medicina (Kaunas). 2023;59(3):501. DOI: 10.3390/medicina59030501.

DOI: 10.3390/medicina59030501

41. Kim JE, Park J, Min YG, Hong YH, Song TJ. Associations of neuralgic amyotrophy with COVID-19 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database. Muscle Nerve. 2022; 66(6):766-70. DOI: 10.1002/mus.27734.

DOI: 10.1002/mus.27734

42. Noseda R, Ripellino P, Ghidossi S, Bertoli R, Ceschi A. Reporting of acute inflammatory neuropathies with COVID-19 vaccines: Subgroup disproportionality analyses in VigiBase. Vaccines. 2021;9(9):1022. DOI: 10.3390/vaccines9091022.

DOI: 10.3390/vaccines9091022

43. Arce Gálvez L, Benavides Ramírez A, Mancera Álzate JM. Dolor y rehabilitación en síndrome de Parsonage-Tuner por SARS-COV-2: a propósito de un caso. Rev Soc Esp Dolor. 2022;29(2):1-5.

Tablas y Figuras

Figura 1

Figura 2

Tabla I

Instrucciones para citar

Linares R, Linares J, Rubiano H, Gutiérrez J. Síndrome de Parsonage-Turner: presentación atípica posterior a vacuna para COVID-19. Reporte de un caso y revisión de la literatura. Rev Soc Esp Dolor 2024; 31(3): 169-175 / DOI: 1020986/resed20254120/2023

Descargar a un gestores de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica

Este artículo ha sido visitado 60 veces.
Este artículo ha sido descargado 6 veces.

Estadísticas de Dimensions

Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 24/11/2023

Aceptado: 17/04/2025

Prepublicado: 21/05/2025

Publicado: 01/10/2025

Tiempo de prepublicación: 544 días

Tiempo de edición del artículo: 677 días

Este artículo aun no tiene valoraciones.

Valoración del lector:

Valora este artículo:

Enviar por e-mail

Gestión de Cookies	Nombre	Tipo de Cookie	Función
Google	NID, PREF	Persistente	Personalizar los anuncios que se muestran en los servicios de Google.
Google Analytics	__utma, __utmb, __utmc, __utmz	Persistente	Conocer de forma anónima, nº de visitantes, procedencia, páginas visitadas, etc.